Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Klingebiel
T
T
Department of Hematology, University of Tübingen, FRG.
Bruchelt
G
G
Kaleva
N
N
Wollmann
H
H
Handgretinger
R
R
Treuner
J
J
Gupta
D
D
Niethammer
D
D
D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004744:Enkephalin, Methionine / Q000097:blood*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000627:therapeutic use*; D009447:Neuroblastoma / Q000097:blood / Q000473:pathology / Q000503:physiopathology* / Q000532:radiotherapy; D010146:Pain / Q000097:blood / Q000503:physiopathology*; D013997:Time Factors; D001615:beta-Endorphin / Q000097:blood*
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine; D004744:Enkephalin, Methionine; D001615:beta-Endorphin